Expansion of government screening programs, rise in prevalence of hepatitis c & need for its early detection, and advancements in diagnostic technologies drive the growth of the global hepatitis C ...

Quanterix (NASDAQ:QTRX – Get Free Report) had its price target lowered by equities research analysts at Canaccord Genuity ...

ABT's shares rise on the back of its diversified business portfolio. However, the unfavorable macroeconomic scenario is concerning.

Learn more about whether Globus Medical, Inc. or QuidelOrtho Corporation is a better investment based on AAII's A+ Investor ...

Sera Prognostics Inc ( NASDAQ: SERA) Q4 2024 Earnings Conference Call March 19, 2025 5:00 PM ET Peter DeNardo - IR, CapComm Partners Evguenia Lindgardt - President, CEO & Director Austin Aerts - CFO ...

The global therapeutic drug monitoring market is poised for significant expansion, with projections indicating a rise from USD 1,203.9 million in 2024 to an impressive USD 2,527.9 million by 2034.

US Bancorp DE cut its holdings in shares of QuidelOrtho Co. (NASDAQ:QDEL – Free Report) by 25.7% during the fourth quarter, ...

Remarkable technological advancements have shaped the history of medicine for over 150 years. Historical breakthroughs have ...

It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides ...

CLEO Diagnostics (ASX:COV), a company developing a simple blood test for ovarian cancer for use in surgical triage, has ...

Abbott Laboratories has experienced a 12.7% rise in stock price over the past year, outperforming the industry’s 9% growth.